Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1984;63:57-60
© 1984 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YLIKORKALA, O.
Right arrow Articles by VIINIKKA, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YLIKORKALA, O.
Right arrow Articles by VIINIKKA, L.

Treatment of Inadequate Lactation With Oral Sulpiride and Buccal Oxytocin

O. YLIKORKALA, A. KAUPPILA, S. KIVINEN and L. VIINIKKA

From the Departments of Obstetrics and Gynecology, and Clinical Chemistry, University of Oulu, Finland.

Abstract

Thirty-six puerperal women with inadequate lactation were treated with 50 mg sulpiride N = 24) or placebo (N = 12) three times a day for two weeks. These treatments were supplemented with buccal oxytocin (100 IU, 300 IU, or 400 IU) or placebo preceding each breast-feeding on the sixth and 14th and on the seventh and 13th days of oral treatment, respectively. One woman treated with sulpiride and three women treated with placebo discontinued the trial because of the lack of the effect of treatment. The concentration of prolactin in maternal serum was higher (P <.001) during sulpiride than placebo treatment at one week (380 ± 43 ng/ml vs 23 ± 7 ng/ml, mean ± SE) and two weeks of treatment (381 ± 38 ng/ml vs 34 ± 10 ng/ml). Also, the daily breast milk yield, as measured objectively, was greater (P < .05) during sulpiride than placebo treatment both at one week (628 ± 51 ml vs 440 ± 68 ml) and two weeks of treatment (684 ± 67 ml vs 423 ± 60 ml). Various doses of oxytocin failed to stimulate the milk secretion in the presence or absence of sulpiride-induced hyperprolactinemia. Thus, sulpiride improved inadequate lactation, whereas exogenous oxytocin alone or together with sulpiride had no effect on lactation in these mothers whose infants were able to suckle normally.




This article has been cited by other articles:


Home page
J Hum LactHome page
M. P. Gabay
Galactogogues: Medications That Induce Lactation
J Hum Lact, August 1, 2002; 18(3): 274 - 279.
[Abstract] [PDF]


Home page
Biol Res NursHome page
P. D. Hill, R. T. Chatterton Jr., and J. C. Aldag
Serum Prolactin in Breastfeeding: State of the Science
Biol Res Nurs, July 1, 1999; 1(1): 65 - 75.
[Abstract] [PDF]


Home page
J Hum LactHome page
M. M. Emery
Galactogogues: Drugs to Induce Lactation
J Hum Lact, March 1, 1996; 12(1): 55 - 57.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American College of Obstetricians and Gynecologists.